comparemela.com

Latest Breaking News On - ஆரியெஂட் மின்சார - Page 5 : comparemela.com

Orient Electric share price: Buy Orient Electric, target price Rs 365: Motilal Oswal

Orient Electric standalone net profit rises 75 15% in the March 2021 quarter

Orient Electric standalone net profit rises 75 15% in the March 2021 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Nifty today: SGX Nifty down 20 points; here s what changed for market while you were sleeping

Weak Asian markets, which are at one-month lows, and a second day s fall in US stocks overnight may hit domestic market sentiment on Wednesday. There are concerns globally that rising inflation in the US will trigger a Fed rate hike soon. Back home, Covid cases in India fell for the third day, raising hopes that the country may soon see a peak in daily cases. Here s breaking down the pre-market actions: STATE OF THE MARKETS Nifty futures on the Singapore Exchange traded 21.50 points, or 0.14 per cent, lower at 14,828.50, signalling that Dalal Street was headed for a negative start on Wednesday.

dr reddy s labs share price: Stocks in the news: Asian Paints, Dr Reddy s Labs, GCPL, Lupin and UPL

Voltas, Vaibhav Global, Happiest Minds, Apollo Tyres, Birla Corp, Prince Pipes and Fittings, Sonata Softwares, Orient Electric, Borosil Renewables and Saregama India are among companies that will announce their March quarter results today. Reliance Industries: India s largest telecom operator Jio widened its mobile subscriber base to 414.9 million in February, with healthy addition of 4.2 million users, as it managed a comfortable lead in the market, according to TRAI data. Dr Reddy s Laboratories: The pharma major said it has inked a licensing pact with Eli Lilly and Company to produce Baricitinib in the country for treatment of COVID-19. The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialisation of the drug in India.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.